---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-101103"
form_type: "8-K"
ticker: "FLGT"
cik: "0001674930"
company_name: "Fulgent Genetics, Inc."
filed_at: "2025-08-01T23:59:59+00:00"
generated_at: "2026-05-17T21:52:05.240055+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Fulgent Q2 core revenue $81.7M (+16% YoY); raises FY2025 guidance to $320M

## Summary
- Core revenue $81.7M, up 16% YoY; total revenue $81.8M.
- GAAP net loss $19.0M ($0.62 per share) includes one-time charge; non-GAAP net income $2.1M ($0.07 per share).
- Adjusted EBITDA loss of $3.0M.
- Raising full-year 2025 core revenue guidance to $320M.
- Cash and investments $777.5M at June 30; repurchased ~130k shares for $2.2M in Q2.

## SEC filing metadata
- accession: 0000950170-25-101103
- form_type: 8-K
- ticker: FLGT
- cik: 0001674930
- company_name: Fulgent Genetics, Inc.
- filed_at: 2025-08-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1674930/000095017025101103/0000950170-25-101103-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1674930/000095017025101103/flgt-20250801.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-101103
- JSON: https://secwatch.observer/filing/0000950170-25-101103.json
- Plain text: https://secwatch.observer/filing/0000950170-25-101103.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.